metoclopramide has been researched along with Disorders of Excessive Somnolence in 2 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Disorders of Excessive Somnolence: Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy and safety of olanzapine when used as an antiemetic in the prevention and treatment of nausea and vomiting related to cancer in adults." | 8.98 | Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults. ( Burton, MJ; Head, K; Naessens, K; Plugge, E; Sutherland, A; Ware, L; Wee, B, 2018) |
| "The hypersomnolence was associated with marked elevations in the serum prolactin level." | 5.29 | Menstrual-associated sleep disorder: an unusual hypersomniac variant associated with both menstruation and amenorrhea with a possible link to prolactin and metoclopramide. ( Bamford, CR, 1993) |
| "To assess the efficacy and safety of olanzapine when used as an antiemetic in the prevention and treatment of nausea and vomiting related to cancer in adults." | 4.98 | Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults. ( Burton, MJ; Head, K; Naessens, K; Plugge, E; Sutherland, A; Ware, L; Wee, B, 2018) |
| "The hypersomnolence was associated with marked elevations in the serum prolactin level." | 1.29 | Menstrual-associated sleep disorder: an unusual hypersomniac variant associated with both menstruation and amenorrhea with a possible link to prolactin and metoclopramide. ( Bamford, CR, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sutherland, A | 1 |
| Naessens, K | 1 |
| Plugge, E | 1 |
| Ware, L | 1 |
| Head, K | 1 |
| Burton, MJ | 1 |
| Wee, B | 1 |
| Bamford, CR | 1 |
1 review available for metoclopramide and Disorders of Excessive Somnolence
| Article | Year |
|---|---|
Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults.
Topics: Adult; Antiemetics; Antineoplastic Agents; Benzodiazepines; Chemoradiotherapy; Dexamethasone; Disord | 2018 |
1 other study available for metoclopramide and Disorders of Excessive Somnolence
| Article | Year |
|---|---|
Menstrual-associated sleep disorder: an unusual hypersomniac variant associated with both menstruation and amenorrhea with a possible link to prolactin and metoclopramide.
Topics: Adult; Amenorrhea; Arthritis, Rheumatoid; Disorders of Excessive Somnolence; Estrogen Replacement Th | 1993 |